New Amsterdam Partners’s Emergent Biosolutions EBS Stock Holding History

New Amsterdam Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$6.23M	Sell	123,288 -73,789	-37%	-$4.35M	2.29%	10
2018 Q4	$11.7M	Sell	197,077 -13,559	-6%	-$874K	3.85%	1
2018 Q3	$13.9M	Sell	210,636 -25,325	-11%	-$1.48M	3.56%	1
2018 Q2	$11.9M	Sell	235,961 -28,605	-11%	-$1.49M	2.82%	4
2018 Q1	$13.9M	Buy	264,566 +3,195	+1%	+$159K	3.04%	3
2017 Q4	$12.1M	Buy	261,371 +98,034	+60%	+$4.13M	2.43%	6
2017 Q3	$6.61M	Buy	163,337 +65,109	+66%	+$2.36M	1.38%	26
2017 Q2	$3.33M	Buy	+98,228	New	+$3.03M	0.71%	56
2016 Q4	–	Sell	-145,797	Closed	-$4.6M	–	130
2016 Q3	$4.6M	Buy	145,797 +37,535	+35%	+$1.09M	1.06%	42
2016 Q2	$3.04M	Sell	108,262 -1,331	-1%	-$52.2K	0.74%	59
2016 Q1	$3.98M	Buy	+109,593	New	+$3.87M	0.42%	66
2015 Q2	–	Sell	-136,116	Closed	-$3.92M	–	120
2015 Q1	$3.92M	Sell	136,116 -37,787	-22%	-$1.08M	0.32%	73
2014 Q4	$4.74M	Buy	173,903 +14,433	+9%	+$344K	0.41%	53
2014 Q3	$3.4M	Buy	159,470 +21,718	+16%	+$497K	0.23%	81
2014 Q2	$3.09M	Buy	137,752 +32,118	+30%	+$748K	0.2%	92
2014 Q1	$2.67M	Buy	+105,634	New	+$2.67M	0.18%	93

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

New Amsterdam Partners's EBS Position: Q1 2019 in Review

New Amsterdam Partners reduced its Emergent Biosolutions (EBS) stake by 37% in Q1 2019, selling an estimated $4.35M and leaving 123,288 shares worth $6.23M. The position accounts for 2.29% of the portfolio, ranked #10.

New Amsterdam Partners first reported a position in EBS in Q1 2014 and has held it in 16 quarters since. The position peaked at $13.9M in Q1 2018. 272 funds tracked by Wall St. Rank hold EBS as of Q1 2019.

New Amsterdam Partners held 123,288 shares of Emergent Biosolutions worth $6.23M as of Q1 2019.
New Amsterdam Partners sold 73,789 Emergent Biosolutions shares in Q1 2019, an estimated $4.35M.
Emergent Biosolutions made up 2.29% of New Amsterdam Partners's portfolio in Q1 2019, its #10 holding.
New Amsterdam Partners first reported a position in Emergent Biosolutions in Q1 2014 and has held it in 16 quarters since.
New Amsterdam Partners's Emergent Biosolutions position peaked at $13.9M in Q1 2018.
272 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2019.

Based on New Amsterdam Partners's 13F filing for Q1 2019, filed 2 May 2019.